美国 · SEC FORM 4
ADMA BIOLOGICS, INC.
ADMA · Nasdaq · CIK 0001368514 · Healthcare · Biotechnology
内部人信号
1 位买方 · 3 条买入交易行 · $250.9K 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Purchase activity is becoming less recent
- ✓ 角色得分高 · 买入者中职位最高的是:Director
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
信号历史
最新留档分数
- 49.5
- 49.5
- 49.4
- 49.4
- 49.4
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- +5.5%
- 3M
- +9.8%
- 6M
- +8.9%
- 12M
- -30.4%
波动率与流动性
- 波动率
- 56.6%
- Beta
- 0.69
- 平均每日成交额
- USD 26.4M
估值
- 市值
- USD 2.3B
- P/E
- 14.4×
基本面
- 利润率
- 28.8%
- ROE
- 30.8%
- 细分行业
- Biotechnology
市场数据
价格数据截至:2026-10-05 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:利润率, ROE · 财年截止日:2025-12-31 · 来自 Yahoo Finance:市值, P/E · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 20,597,867
- 上期报告
- 24,206,749
- 日均成交量
- 3,633,588
- 回补天数
- 5.7
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Grossman Jerrold B | 买入 (P) | Common Stock | 6,400 | USD 7.91 | USD 50,624 | SEC 申报 ↗ |
| 2026-05-12 | Grossman Jerrold B | 买入 (P) | Common Stock | 12,500 | USD 8.01 | USD 100,125 | SEC 申报 ↗ |
| 2026-05-11 | Grossman Jerrold B | 买入 (P) | Common Stock | 12,500 | USD 8.01 | USD 100,125 | SEC 申报 ↗ |
| 2026-03-06 | ELMS STEVE | 买入 (P) | Common Stock | 7,000 | USD 15.39 | USD 107,730 | SEC 申报 ↗ |
| 2026-03-05 | ELMS STEVE | 买入 (P) | Common Stock | 7,000 | USD 15.67 | USD 109,690 | SEC 申报 ↗ |
| 2023-08-30 | Grossman Jerrold B | 买入 (P) | Common Stock | 130,000 | USD 3.71 | USD 482,300 | SEC 申报 ↗ |
| 2023-08-24 | KWON YOUNG | 买入 (P) | Common Stock | 25,000 | USD 3.90 | USD 97,500 | SEC 申报 ↗ |
| 2022-12-09 | LENZ BRIAN | 买入 (P) | Common Stock | 6,993 | USD 2.86 | USD 20,000 | SEC 申报 ↗ |
| 2022-12-09 | Grossman Adam S | 买入 (P) | Common Stock | 29,965 | USD 2.86 | USD 85,700 | SEC 申报 ↗ |
| 2021-10-25 | LENZ BRIAN | 买入 (P) | Common Stock | 30,000 | USD 1.00 | USD 30,000 | SEC 申报 ↗ |
| 2021-10-25 | KWON YOUNG | 买入 (P) | Common Stock | 100,000 | USD 1.00 | USD 100,000 | SEC 申报 ↗ |
| 2021-10-25 | Grossman Jerrold B | 买入 (P) | Common Stock | 100,000 | USD 1.00 | USD 100,000 | SEC 申报 ↗ |
| 2021-10-25 | Grossman Adam S | 买入 (P) | Common Stock | 350,000 | USD 1.00 | USD 350,000 | SEC 申报 ↗ |
| 2020-09-11 | DEMSKI MARTHA J | 买入 (P) | Common Stock | 2,200 | USD 2.29 | USD 5,038 | SEC 申报 ↗ |
| 2020-09-10 | Grossman Jerrold B | 买入 (P) | Common Stock | 5,000 | USD 2.22 | USD 11,100 | SEC 申报 ↗ |
Form 4 申报证据
48 transaction lines in the latest 365-day window; 297 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Kestenberg-Messina Kaitlin M. | 代扣税 (F) | Common Stock | 3,177 | USD 8.37 | USD 26,591 | SEC 申报 ↗ |
| 2026-07-16 | Kohler Terry | 奖励/授予 (A) | Common Stock | 85,130 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-27 | Grossman Jerrold B | 买入 (P) | Common Stock | 6,400 | USD 7.91 | USD 50,624 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Kestenberg-Messina Kaitlin M. | 代扣税 (F) | Common Stock | 3,177 | USD 8.37 | USD 26,591 | SEC 申报 ↗ |
| 2026-07-16 | Kohler Terry | 奖励/授予 (A) | Common Stock | 85,130 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-27 | Grossman Jerrold B | 买入 (P) | Common Stock | 6,400 | USD 7.91 | USD 50,624 | SEC 申报 ↗ |
| 2026-05-12 | Grossman Jerrold B | 买入 (P) | Common Stock | 12,500 | USD 8.01 | USD 100,125 | SEC 申报 ↗ |
| 2026-05-11 | Grossman Jerrold B | 买入 (P) | Common Stock | 12,500 | USD 8.01 | USD 100,125 | SEC 申报 ↗ |
| 2026-04-01 | Kestenberg-Messina Kaitlin M. | 代扣税 (F) | Common Stock | 20,362 | USD 9.11 | USD 185,498 | SEC 申报 ↗ |
| 2026-03-17 | Guiheen Lawrence P. | 赠与 (G) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-16 | Grossman Adam S | 卖出 (S) | Common Stock | 21,000 | USD 15.16 | USD 318,360 | SEC 申报 ↗ |
| 2026-03-16 | Grossman Adam S | 期权行权/转换 (M) | Common Stock | 15,000 | USD 5.40 | USD 81,000 | SEC 申报 ↗ |
| 2026-03-13 | Guiheen Lawrence P. | 期权行权/转换 (M) | Common Stock | 30,000 | USD 3.66 | USD 109,800 | SEC 申报 ↗ |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | 卖出 (S) | Common Stock | 10,096 | USD 15.63 | USD 157,800 | SEC 申报 ↗ |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | 期权行权/转换 (M) | Common Stock | 10,096 | USD 3.20 | USD 32,331 | SEC 申报 ↗ |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | J (J) | Common Stock | 91,266 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-07 | Kestenberg-Messina Kaitlin M. | 代扣税 (F) | Common Stock | 4,235 | USD 15.39 | USD 65,177 | SEC 申报 ↗ |
| 2026-03-07 | Grossman Adam S | 代扣税 (F) | Common Stock | 29,513 | USD 15.39 | USD 454,205 | SEC 申报 ↗ |
| 2026-03-06 | Kestenberg-Messina Kaitlin M. | 代扣税 (F) | Common Stock | 10,059 | USD 15.39 | USD 154,808 | SEC 申报 ↗ |
| 2026-03-06 | Grossman Adam S | 代扣税 (F) | Common Stock | 56,438 | USD 15.39 | USD 868,581 | SEC 申报 ↗ |
| 2026-03-06 | ELMS STEVE | 买入 (P) | Common Stock | 7,000 | USD 15.39 | USD 107,730 | SEC 申报 ↗ |
| 2026-03-05 | ELMS STEVE | 买入 (P) | Common Stock | 7,000 | USD 15.67 | USD 109,690 | SEC 申报 ↗ |
| 2026-02-26 | Grossman Adam S | 代扣税 (F) | Common Stock | 54,858 | USD 15.18 | USD 832,744 | SEC 申报 ↗ |
| 2026-02-19 | Tade Brad L. | 代扣税 (F) | Common Stock | 6,479 | USD 16.32 | USD 105,737 | SEC 申报 ↗ |
| 2026-02-19 | Kestenberg-Messina Kaitlin M. | 代扣税 (F) | Common Stock | 8,161 | USD 16.32 | USD 133,188 | SEC 申报 ↗ |
| 2026-02-19 | Grossman Adam S | 代扣税 (F) | Common Stock | 24,793 | USD 16.32 | USD 404,622 | SEC 申报 ↗ |
| 2026-02-17 | Grossman Adam S | 卖出 (S) | Common Stock | 21,000 | USD 16.08 | USD 337,680 | SEC 申报 ↗ |
| 2026-02-17 | Grossman Adam S | 期权行权/转换 (M) | Common Stock | 15,000 | USD 5.40 | USD 81,000 | SEC 申报 ↗ |
| 2026-02-09 | Salas Eduardo Rene | 奖励/授予 (A) | Common Stock | 10,690 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | Kestenberg-Messina Kaitlin M. | 奖励/授予 (A) | Common Stock | 91,631 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | KWON YOUNG | 奖励/授予 (A) | Common Stock | 10,690 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | Guiheen Lawrence P. | 奖励/授予 (A) | Common Stock | 10,690 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | Grossman Jerrold B | 奖励/授予 (A) | Common Stock | 10,690 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ADMA |
| CIK | 0001368514 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 297 transaction lines from 2020-02-11 to 2026-07-24 40 P purchase lines · 61 S sale lines · 196 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.